United States · Series D startup
6 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$167Mraised across 6 rounds since 2008, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Kleiner Perkins Caufield & Byers
Mohr Davidow Ventures
Safeguard Scientifics
Skyline VenturesReported by pevc.dowjones.comSEC filing: $28M sold, first sale Dec 2012
No investor was named in the report.
Reported by sec.govSEC filing: $25M sold, first sale Sept 2011
Reported by crescendobio.comSEC filing: $25M sold, first sale Sept 2011
From a historical funding recordSEC filing: $38M sold, first sale Jun 2008
Reported by deals.venturebeat.comSEC filing: $20M sold, first sale Jun 2008
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Kleiner Perkins Caufield & ByersMohr Davidow VenturesAeris CapitalSafeguard ScientificsSkyline VenturesFrom historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
Crescendo Bioscience's investors include Kleiner Perkins Caufield & Byers, Mohr Davidow Ventures, Aeris Capital, Safeguard Scientifics and Skyline Ventures.
Crescendo Bioscience has raised $167M across 6 rounds since 2008.
Crescendo Bioscience's most recent round was a Series D of $28M in Jan 2013.
Crescendo Bioscience's largest round on record is $56M (Series C), in Sept 2011.
Crescendo Bioscience's first round on record, in Jun 2008, was backed by Kleiner Perkins Caufield & Byers and Mohr Davidow Ventures.
Crescendo Bioscience's latest named round is a Series D, in Jan 2013.
Crescendo Bioscience is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·